Determinants of Patient Delay in Seeking Diagnosis and Treatment among Moroccan Women with Cervical Cancer

Table 4

Association between clinical factors and patient delay, identified by multivariate analysis.

Categorial variables	≤90 days; ()	>90 days; ()	Univariate analysis			Multivariate analysis
	(%)	(%)	OR	95% CI		OR	95% CI
Medical history
Yes	52 (50)	52 (50)
No	127 (42.8)	170 (57.2)	1.339	[0.855–2.095]		1.332	[0.827–2.145]	0.238
Earlier symptoms
Abnormal vaginal bleeding (between periods, after sex, postmenopausal)
Yes	158 (46,3)	183 (53,7)	0.335	[0.214–0.523]		0.345	[0.218–0.548]
No	21 (35)	39 (65)
Vaginal discharge
Yes	31 (50)	31 (50)
No	148 (43,7)	191 (56,3)	1.014	[0.602–1.708]	0.958
Pain (painful sex, pelvic pain, dysuria)
Yes	92 (39.8)	139 (60.2)
No	87 (51.2)	83 (48.8)	0.631	[0.423–0.942]		1.255	[0.812–1.940]	0.307
Personal history of cancer
Yes	2 (66.7)	1 (33.3)
No	177 (44.5)	221 (55.5)	2.497	[0.225–27.760]	0.456
Family history of cancer
Yes	23 (56.1)	18 (43.9)
No	156 (43.3)	204 (56.7)	1.671	[0.871–3.204]		1.630	[0.812–3.272]	0.170
Histopathology
Squamous cell	157 (45)	192 (55)
Adenocarcinoma	22 (42.3)	30 (57.7)	1.115	[0.619–2.010]	0.717
Stage at diagnosis
IIA-IIB	129 (53.5)	112 (46.5)
IIIA-IIIB	49 (33.8)	96 (66.2)	2.257	[1.472–3.459]		2.113	[1.348–3.314]
IVA-IVB	1 (6.7)	14 (93.3)	16.121	[2.087–124.507]		11.439	[1.431–91.443]

Model included variables that were significant on univariate analyses at (0.20 level).
Significant at value ≤ 0.05.